IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.795
AS - Asia 4.665
NA - Nord America 4.613
SA - Sud America 784
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 20.946
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.565
US - Stati Uniti d'America 4.530
SG - Singapore 1.684
IE - Irlanda 1.293
CN - Cina 849
HK - Hong Kong 782
BR - Brasile 652
VN - Vietnam 587
DE - Germania 420
IT - Italia 391
UA - Ucraina 318
GB - Regno Unito 310
KR - Corea 216
JP - Giappone 157
IN - India 131
FI - Finlandia 106
SE - Svezia 89
TR - Turchia 83
GR - Grecia 77
FR - Francia 63
AR - Argentina 57
CA - Canada 35
BD - Bangladesh 33
AT - Austria 29
IQ - Iraq 29
PL - Polonia 27
ZA - Sudafrica 27
NL - Olanda 19
CO - Colombia 18
MX - Messico 18
PK - Pakistan 18
BE - Belgio 15
ES - Italia 15
ID - Indonesia 15
EC - Ecuador 14
VE - Venezuela 13
MA - Marocco 10
CZ - Repubblica Ceca 9
IR - Iran 9
PE - Perù 8
RS - Serbia 8
AL - Albania 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
UY - Uruguay 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
JM - Giamaica 6
PA - Panama 6
TN - Tunisia 6
KZ - Kazakistan 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
IL - Israele 4
KG - Kirghizistan 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
SN - Senegal 4
BB - Barbados 3
CM - Camerun 3
GE - Georgia 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CD - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
Totale 20.936
Salva come PNG Salva come JPEG
Città #
Moscow 2.748
Dublin 1.293
Hong Kong 776
Santa Clara 760
Singapore 698
Jacksonville 475
Chandler 438
San Jose 398
Ashburn 285
Seoul 214
Ho Chi Minh City 180
Bremen 178
Princeton 176
Hanoi 149
Roxbury 146
Cambridge 119
Hefei 112
New York 110
Beijing 106
Dallas 96
The Dalles 82
Ann Arbor 73
Caserta 70
Bengaluru 68
Munich 68
São Paulo 63
Los Angeles 59
Medford 58
Boardman 55
Wilmington 46
Da Nang 45
Naples 42
Woodbridge 39
Orem 38
San Mateo 33
Washington 28
Des Moines 26
Haiphong 24
Warsaw 23
Nuremberg 22
Chennai 21
Biên Hòa 20
Frankfurt am Main 18
Helsinki 18
Nanjing 18
London 16
Milan 16
Mountain View 16
Rio de Janeiro 16
Tokyo 16
Brasília 15
Brussels 15
Napoli 15
Vienna 15
Johannesburg 14
Jinan 13
Rome 13
Tianjin 13
Amsterdam 12
Council Bluffs 12
Düsseldorf 12
Hillsboro 12
Manchester 12
Campinas 11
Curitiba 11
Hải Dương 11
Istanbul 11
Mumbai 11
Porto Alegre 11
Stockholm 11
Belo Horizonte 10
Brooklyn 10
Changsha 10
Brno 9
Bến Tre 9
Guangzhou 9
Houston 9
Paris 9
Auburn Hills 8
Aversa 8
Grafing 8
San Francisco 8
Shanghai 8
Shenyang 8
Thái Bình 8
Zhengzhou 8
Atlanta 7
Boston 7
Caxias do Sul 7
Denver 7
Hangzhou 7
Lappeenranta 7
Montreal 7
Nairobi 7
New Delhi 7
Tashkent 7
Thái Nguyên 7
Toronto 7
Amman 6
Ankara 6
Totale 11.079
Salva come PNG Salva come JPEG
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 203
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 198
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 189
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 185
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 177
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 175
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 173
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 173
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 173
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 164
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 163
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 160
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 160
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 159
Absence of occult HCV infection in patients experiencing an immunodepression condition 159
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 154
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 152
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 150
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 149
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 149
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 148
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 148
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 143
Absence of occult HCV infection in HIV-positive patients 142
Clinical and virological characteristics associated with severe acute hepatitis B 136
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 136
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 136
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 136
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 135
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 134
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 133
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 133
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 132
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 129
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 129
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 129
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 128
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 126
Epidemiology and management of hepatitis C virus infections in immigrant populations 126
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 125
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 125
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 123
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 123
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 122
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 122
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 121
Absence of occult HCV infection in HIV-positive patients 121
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 120
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 120
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 120
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 120
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 119
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 118
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 118
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 118
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 117
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 116
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 116
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 116
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 115
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 115
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 114
Role of genetic polymorphisms in hepatitis C virus chronic infection 114
Clinical and virological characteristics associated with severe acute hepatitis B 114
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 114
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 113
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 112
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 112
Occult HBV infection in the oncohematological setting. 112
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 112
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 112
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 111
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 111
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 111
An update on the treatment options for HBV/HCV coinfection 111
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 110
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 110
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 109
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 108
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 108
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 108
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 107
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 107
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 106
Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond 105
Role of occult hepatitis B virus infection in chronic hepatitis C 105
Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report 104
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 104
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 104
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 104
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature 103
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 103
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 103
Management of HBV reactivation in non-oncological patients 103
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 102
The association between education level and chronic liver disease of any etiology 102
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 101
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 101
HBV molecular epidemiology and clinical condition of immigrants living in Italy 101
Totale 12.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021213 0 0 0 0 0 0 0 0 0 109 88 16
2021/2022913 35 15 2 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.141 9 39 14 86 475 439 387 295 527 456 234 180
2025/202612.249 499 594 649 608 1.079 7.033 673 436 462 216 0 0
Totale 21.280